Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma
Author:
Affiliation:
1. Department of Pathology; Graduate School of Biomedical and Health Sciences; Hiroshima University; Hiroshima Japan
2. Department of Surgical Oncology; Research Institute for Radiation Biology and Medicine; Hiroshima University; Hiroshima Japan
Funder
Japan Society for the Promotion of Science
Publisher
Wiley
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Link
https://onlinelibrary.wiley.com/doi/am-pdf/10.1111%2Fhis.13775
Reference20 articles.
1. Advances in malignant mesothelioma;Robinson;N. Engl. J. Med.,2005
2. Malignant pleural mesothelioma: an epidemiological perspective;Robinson;Ann. Cardiothorac. Surg.,2012
3. Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma;Federico;BMC Cancer,2013
4. Radical surgery for malignant pleural mesothelioma: results and prognosis;Okada;Interact. Cardiovasc. Thorac. Surg.,2008
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity;Journal of Experimental & Clinical Cancer Research;2023-10-20
2. Hypothesis: HEG1 and claudin‐4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non‐small ‐cell lung carcinoma with only two stains in most cases;Histopathology;2022-09-05
3. Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of Prognosis;Journal of Oncology;2022-08-26
4. Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21;International Journal of Molecular Sciences;2022-06-16
5. LINC00173 promotes Wilms’ tumor progression through MGAT1-mediated MUC3A N-glycosylation;Cell Cycle;2022-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3